Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
Browsing: Clinical Breakthroughs
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.
Minimally invasive hysterectomy results in worse overall survival outcomes for cancer patients than traditional open surgery, according to a new study.
Northwestern Medicine clinicians are at the forefront in using an advanced surgical treatment called deep brain stimulation to improve quality of life for patients with Parkinson’s and other movement disorders.
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.